# Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis

> **NCT00996788** · PHASE3 · COMPLETED · sponsor: **PT Otsuka Indonesia** · enrollment: 55 (actual)

## Conditions studied

- Dyspepsia
- Chronic Gastritis

## Interventions

- **DRUG:** Rebamipide

## Key facts

- **NCT ID:** NCT00996788
- **Lead sponsor:** PT Otsuka Indonesia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2013-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00996788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00996788, "Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00996788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*